The specific roles of N6-methyladenosine (m6A) regulatory genes in pancreatic
adenocarcinoma (PAAD) have not been fully elucidated. In present study, a novel risk …

Background Pancreatic adenocarcinoma (PAAD) is among the most lethal diseases and has
a dismal prognosis; however, efficient treatment is currently limited. Several studies have …

Background Several studies have revealed that N6-methyladenosine (m6A) regulation is
involved in various biological processes and cancer progression. Nevertheless, the potential …

Abstract Background N6-methyladenosine (m6A) is the most abundant mRNA modification.
Whether m6A regulators can determine tumor aggressiveness and risk of immune evasion …

Pancreatic carcinogenesis is a complicated and multi-step process. It is substantially
assisted by N6-methyladenosine (m6A) RNA modification, especially when mutations of …

Recent studies have shown that RNA N6-methyladenosine (m6A) modification plays an
important part in tumorigenesis and immune-related biological processes. However, the …

Pancreatic cancer (PC) has a very poor prognosis and is usually diagnosed only at an
advanced stage. The discovery of new biomarkers for PC will help in early diagnosis and a …

Background: N6-methyladenosine (m6A) is related to the progression of multiple cancers.
However, the underlying influences of m6A-associated genes on the tumor immune …

Background N6-methyladenosine (m6A)-mediated ribonucleic acid (RNA) methylation is
considered to be the most significant and abundant epigenetic modification in eukaryotic …

Background m6A is the most prevalent and abundant form of mRNA modifications and is
closely related to tumor proliferation, differentiation, and tumorigenesis. In this study, we try …